|
2024
|
Invention
|
Cannula system and use thereof.
The present disclosure relates to cannula systems for delivery o... |
|
|
Invention
|
Compositions and methods for the treatment of disorders related to frataxin deficiency. e.g.e.g.,... |
|
|
Invention
|
Compositions and methods for the treatment of disorders related to dystrophia myotonica protein k... |
|
|
Invention
|
Compositions and methods for the treatment of disorders related to cdkl5 deficiency. The disclosu... |
|
|
Invention
|
Compositions and methods for the treatment of disorders related to ataxin-2. e.g.e.g., reducing o... |
|
|
Invention
|
Compositions and methods for the treatment of disorders related to glucosylceramidase beta 1 defi... |
|
|
Invention
|
Aav capsid variants and uses thereof. The disclosure relates to compositions and methods for the ... |
|
|
Invention
|
Treatment of amyotrophic lateral sclerosis (als).
The present invention relates to AAVs encoding... |
|
|
Invention
|
Aav capsid variants and uses thereof.
The disclosure relates to compositions and methods for the... |
|
|
Invention
|
Tau binding compounds.
The present disclosure provides anti-tau antibodies and vectorization the... |
|
|
P/S
|
Biological preparations for gene therapy; adeno-associated virus (aav) gene therapy preparations ... |
|
|
P/S
|
Biological preparations for gene therapy; adeno-associated
virus (aav) gene therapy preparations... |
|
|
Invention
|
Compositions and methods for the treatment of tau-related disorders. The disclosure provides comp... |
|
|
Invention
|
Compositions and methods for the treatment of disorders related to frataxin deficiency. inter ali... |
|
|
Invention
|
Compositions and methods for the treatment of disorders related to cdkl5 deficiency. e.g.e.g., en... |
|
|
Invention
|
Compositions and methods for the treatment of disorders related to syntaxin-binding protein 1 def... |
|
|
Invention
|
Compositions and methods for regulating mapt. The disclosure relates to small interfering RNA (si... |
|
|
Invention
|
Compositions and methods for treating amyotrophic lateral sclerosis. The present disclosure relat... |
|
|
Invention
|
Aadc polynucleotides for the treatment of parkinson's disease.
The disclosure relates to composi... |
|
|
Invention
|
Compositions and methods for treating huntington's disease.
The present invention relates to sma... |
|
|
P/S
|
Biological preparations for gene therapy; adeno-associated
virus (AAY) gene therapy preparations... |
|
|
Invention
|
Treatment of amyotrophic lateral sclerosis (als).
The present disclosure relates to AAVs encodin... |
|
|
Invention
|
Baculovirus expression system. The disclosure provides variant viral genomes, e.g., variant bacul... |
|
2023
|
Invention
|
Central nervous system targeting polynucleotides.
The present disclosure relates to compositions... |
|
|
Invention
|
Aav capsids with increased tropism to brain tissue.
The disclosure relates to compositions, meth... |
|
|
Invention
|
Tau binding compounds. The present disclosure provides anti-tau antibodies and vectorization ther... |
|
|
Invention
|
Controlled expression of viral proteins. Spodoptera frugiperda Spodoptera frugiperda insect cells... |
|
|
P/S
|
Biological preparations for gene therapy; adeno-associated virus (AAV) gene therapy preparations ... |
|
|
Invention
|
Compositions and methods for crossing the blood brain barrier. The disclosure relates to composit... |
|
|
Invention
|
Compositions and methods of treating huntington's disease.
The present invention relates to aden... |
|
|
Invention
|
Tau binding compounds. The present disclosure provides anti-tau antibodies and adeno-associated v... |
|
|
Invention
|
Compositions and methods for the treatment of spinal muscular atrophy related disorders. The disc... |
|
|
Invention
|
Aav capsid variants and uses thereof |
|
|
Invention
|
Compositions and methods for the treatment of her2 positive cancer. The disclosure provides compo... |
|
|
Invention
|
Compositions and methods for the treatment of neurological disorders related to glucosylceramidas... |
|
2022
|
Invention
|
Compositions and methods of treating amyotrophic lateral sclerosis (als). The present invention r... |
|
|
Invention
|
Compositions and methods for the treatment of tau-related disorders.
The disclosure provides com... |
|
|
Invention
|
Compositons and methods for the treatment of neurological disorders related to glucosylceramidase... |
|
|
Invention
|
Controlled expression of viral proteins.
The present disclosure describes methods and systems fo... |
|
|
P/S
|
Biological preparations for gene therapy; adeno-associated virus (AAV) gene therapy; Biological p... |
|
2021
|
Invention
|
Tau binding compounds.
The present disclosure provides anti-tau antibodies. Also provided are me... |
|
|
Invention
|
Compositions and methods for the treatment of tauopathy.
The disclosure provides compositions an... |
|
|
P/S
|
Biotechnology research services; research and development of platform technologies for genetic de... |
|
|
P/S
|
Biological preparations for gene therapy; Biological preparations for treatment of neurological d... |
|
|
P/S
|
Biological preparations for gene therapy, namely, the treatment of Huntington's disease, Gaucher ... |
|
2020
|
Invention
|
Compositions and methods for the vectored augmentation of protein destruction, expression and/or ... |
|
2018
|
P/S
|
Medical system comprised of a surgical device for guiding, locating or placing a diagnostic devic... |
|
2014
|
P/S
|
Pharmaceutical research and development in the field of gene therapy |
